| Day Range16.990 - 17.930 | 52 Wk Range14.870 - 23.400 | Open / Close17.000 / 17.760 | Float / Outstanding285.391M / 324.087M |
| Vol / Avg.3.425M / 2.323M | Mkt Cap5.756B | P/E31.714 | 50d Avg. Price16.650 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float285.391M | EPS0.960 |
Exelixis Stock (NASDAQ:EXEL), Quotes and News Summary
Exelixis Stock (NASDAQ: EXEL) stock price, news, charts, stock research, profile.
| Day Range16.990 - 17.930 | 52 Wk Range14.870 - 23.400 | Open / Close17.000 / 17.760 | Float / Outstanding285.391M / 324.087M |
| Vol / Avg.3.425M / 2.323M | Mkt Cap5.756B | P/E31.714 | 50d Avg. Price16.650 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float285.391M | EPS0.960 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-09 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.030 | 0.0900 | ||||
| REV | 417.500M | 423.917M | 6.417M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Exelixis (EXEL) stock?
You can purchase shares of Exelixis (NASDAQ: EXEL) through any online brokerage.
Who are Exelixis's (EXEL) competitors?
Other companies in Exelixis’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Exelixis (EXEL) stock?
The latest price target for Exelixis (NASDAQ: EXEL) was reported by Piper Sandler on Wednesday, February 8, 2023. The analyst firm set a price target for 32.00 expecting EXEL to rise to within 12 months (a possible 80.18% upside). 14 analyst firms have reported ratings in the last year.
Current Stock Price for Exelixis (EXEL)?
The stock price for Exelixis (NASDAQ: EXEL) is $17.76 last updated February 8, 2023 at 9:00 PM UTC.
Does Exelixis (EXEL) pay a dividend?
There are no upcoming dividends for Exelixis.
When is Exelixis (NASDAQ:EXEL) reporting earnings?
Exelixis’s Q1 earnings are confirmed for Tuesday, May 9, 2023.
Is Exelixis (EXEL) going to split?
There is no upcoming split for Exelixis.
What sector and industry does Exelixis (EXEL) operate in?
Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Exelixis Stock (NASDAQ:EXEL), Quotes and News Summary
Exelixis Stock (NASDAQ: EXEL) stock price, news, charts, stock research, profile.
| Day Range16.990 - 17.930 | 52 Wk Range14.870 - 23.400 | Open / Close17.000 / 17.760 | Float / Outstanding285.391M / 324.087M |
| Vol / Avg.3.425M / 2.323M | Mkt Cap5.756B | P/E31.714 | 50d Avg. Price16.650 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float285.391M | EPS0.960 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-09 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.030 | 0.0900 | ||||
| REV | 417.500M | 423.917M | 6.417M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Exelixis (EXEL) stock?
You can purchase shares of Exelixis (NASDAQ: EXEL) through any online brokerage.
Who are Exelixis's (EXEL) competitors?
Other companies in Exelixis’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Exelixis (EXEL) stock?
The latest price target for Exelixis (NASDAQ: EXEL) was reported by Piper Sandler on Wednesday, February 8, 2023. The analyst firm set a price target for 32.00 expecting EXEL to rise to within 12 months (a possible 80.18% upside). 14 analyst firms have reported ratings in the last year.
Current Stock Price for Exelixis (EXEL)?
The stock price for Exelixis (NASDAQ: EXEL) is $17.76 last updated February 8, 2023 at 9:00 PM UTC.
Does Exelixis (EXEL) pay a dividend?
There are no upcoming dividends for Exelixis.
When is Exelixis (NASDAQ:EXEL) reporting earnings?
Exelixis’s Q1 earnings are confirmed for Tuesday, May 9, 2023.
Is Exelixis (EXEL) going to split?
There is no upcoming split for Exelixis.
What sector and industry does Exelixis (EXEL) operate in?
Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Exelixis Stock (NASDAQ:EXEL), Quotes and News Summary
Exelixis Stock (NASDAQ: EXEL) stock price, news, charts, stock research, profile.
| Day Range16.990 - 17.930 | 52 Wk Range14.870 - 23.400 | Open / Close17.000 / 17.760 | Float / Outstanding285.391M / 324.087M |
| Vol / Avg.3.425M / 2.323M | Mkt Cap5.756B | P/E31.714 | 50d Avg. Price16.650 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float285.391M | EPS0.960 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-09 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.030 | 0.0900 | ||||
| REV | 417.500M | 423.917M | 6.417M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Exelixis (EXEL) stock?
You can purchase shares of Exelixis (NASDAQ: EXEL) through any online brokerage.
Who are Exelixis's (EXEL) competitors?
Other companies in Exelixis’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Exelixis (EXEL) stock?
The latest price target for Exelixis (NASDAQ: EXEL) was reported by Piper Sandler on Wednesday, February 8, 2023. The analyst firm set a price target for 32.00 expecting EXEL to rise to within 12 months (a possible 80.18% upside). 14 analyst firms have reported ratings in the last year.
Current Stock Price for Exelixis (EXEL)?
The stock price for Exelixis (NASDAQ: EXEL) is $17.76 last updated February 8, 2023 at 9:00 PM UTC.
Does Exelixis (EXEL) pay a dividend?
There are no upcoming dividends for Exelixis.
When is Exelixis (NASDAQ:EXEL) reporting earnings?
Exelixis’s Q1 earnings are confirmed for Tuesday, May 9, 2023.
Is Exelixis (EXEL) going to split?
There is no upcoming split for Exelixis.
What sector and industry does Exelixis (EXEL) operate in?
Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Exelixis Stock (NASDAQ:EXEL), Quotes and News Summary
Exelixis Stock (NASDAQ: EXEL) stock price, news, charts, stock research, profile.
| Day Range16.990 - 17.930 | 52 Wk Range14.870 - 23.400 | Open / Close17.000 / 17.760 | Float / Outstanding285.391M / 324.087M |
| Vol / Avg.3.425M / 2.323M | Mkt Cap5.756B | P/E31.714 | 50d Avg. Price16.650 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float285.391M | EPS0.960 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-09 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.030 | 0.0900 | ||||
| REV | 417.500M | 423.917M | 6.417M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Exelixis (EXEL) stock?
You can purchase shares of Exelixis (NASDAQ: EXEL) through any online brokerage.
Who are Exelixis's (EXEL) competitors?
Other companies in Exelixis’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Exelixis (EXEL) stock?
The latest price target for Exelixis (NASDAQ: EXEL) was reported by Piper Sandler on Wednesday, February 8, 2023. The analyst firm set a price target for 32.00 expecting EXEL to rise to within 12 months (a possible 80.18% upside). 14 analyst firms have reported ratings in the last year.
Current Stock Price for Exelixis (EXEL)?
The stock price for Exelixis (NASDAQ: EXEL) is $17.76 last updated February 8, 2023 at 9:00 PM UTC.
Does Exelixis (EXEL) pay a dividend?
There are no upcoming dividends for Exelixis.
When is Exelixis (NASDAQ:EXEL) reporting earnings?
Exelixis’s Q1 earnings are confirmed for Tuesday, May 9, 2023.
Is Exelixis (EXEL) going to split?
There is no upcoming split for Exelixis.
What sector and industry does Exelixis (EXEL) operate in?
Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Exelixis Stock (NASDAQ:EXEL), Quotes and News Summary
Exelixis Stock (NASDAQ: EXEL) stock price, news, charts, stock research, profile.
| Day Range16.990 - 17.930 | 52 Wk Range14.870 - 23.400 | Open / Close17.000 / 17.760 | Float / Outstanding285.391M / 324.087M |
| Vol / Avg.3.425M / 2.323M | Mkt Cap5.756B | P/E31.714 | 50d Avg. Price16.650 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float285.391M | EPS0.960 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-09 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.030 | 0.0900 | ||||
| REV | 417.500M | 423.917M | 6.417M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Exelixis (EXEL) stock?
You can purchase shares of Exelixis (NASDAQ: EXEL) through any online brokerage.
Who are Exelixis's (EXEL) competitors?
Other companies in Exelixis’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Exelixis (EXEL) stock?
The latest price target for Exelixis (NASDAQ: EXEL) was reported by Piper Sandler on Wednesday, February 8, 2023. The analyst firm set a price target for 32.00 expecting EXEL to rise to within 12 months (a possible 80.18% upside). 14 analyst firms have reported ratings in the last year.
Current Stock Price for Exelixis (EXEL)?
The stock price for Exelixis (NASDAQ: EXEL) is $17.76 last updated February 8, 2023 at 9:00 PM UTC.
Does Exelixis (EXEL) pay a dividend?
There are no upcoming dividends for Exelixis.
When is Exelixis (NASDAQ:EXEL) reporting earnings?
Exelixis’s Q1 earnings are confirmed for Tuesday, May 9, 2023.
Is Exelixis (EXEL) going to split?
There is no upcoming split for Exelixis.
What sector and industry does Exelixis (EXEL) operate in?
Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Exelixis Stock (NASDAQ:EXEL), Quotes and News Summary
Exelixis Stock (NASDAQ: EXEL) stock price, news, charts, stock research, profile.
| Day Range16.990 - 17.930 | 52 Wk Range14.870 - 23.400 | Open / Close17.000 / 17.760 | Float / Outstanding285.391M / 324.087M |
| Vol / Avg.3.425M / 2.323M | Mkt Cap5.756B | P/E31.714 | 50d Avg. Price16.650 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float285.391M | EPS0.960 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-09 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.030 | 0.0900 | ||||
| REV | 417.500M | 423.917M | 6.417M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Exelixis (EXEL) stock?
You can purchase shares of Exelixis (NASDAQ: EXEL) through any online brokerage.
Who are Exelixis's (EXEL) competitors?
Other companies in Exelixis’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Exelixis (EXEL) stock?
The latest price target for Exelixis (NASDAQ: EXEL) was reported by Piper Sandler on Wednesday, February 8, 2023. The analyst firm set a price target for 32.00 expecting EXEL to rise to within 12 months (a possible 80.18% upside). 14 analyst firms have reported ratings in the last year.
Current Stock Price for Exelixis (EXEL)?
The stock price for Exelixis (NASDAQ: EXEL) is $17.76 last updated February 8, 2023 at 9:00 PM UTC.
Does Exelixis (EXEL) pay a dividend?
There are no upcoming dividends for Exelixis.
When is Exelixis (NASDAQ:EXEL) reporting earnings?
Exelixis’s Q1 earnings are confirmed for Tuesday, May 9, 2023.
Is Exelixis (EXEL) going to split?
There is no upcoming split for Exelixis.
What sector and industry does Exelixis (EXEL) operate in?
Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Exelixis Stock (NASDAQ:EXEL), Quotes and News Summary
Exelixis Stock (NASDAQ: EXEL) stock price, news, charts, stock research, profile.
| Day Range16.990 - 17.930 | 52 Wk Range14.870 - 23.400 | Open / Close17.000 / 17.760 | Float / Outstanding285.391M / 324.087M |
| Vol / Avg.3.425M / 2.323M | Mkt Cap5.756B | P/E31.714 | 50d Avg. Price16.650 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float285.391M | EPS0.960 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-09 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.030 | 0.0900 | ||||
| REV | 417.500M | 423.917M | 6.417M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Exelixis (EXEL) stock?
You can purchase shares of Exelixis (NASDAQ: EXEL) through any online brokerage.
Who are Exelixis's (EXEL) competitors?
Other companies in Exelixis’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Exelixis (EXEL) stock?
The latest price target for Exelixis (NASDAQ: EXEL) was reported by Piper Sandler on Wednesday, February 8, 2023. The analyst firm set a price target for 32.00 expecting EXEL to rise to within 12 months (a possible 80.18% upside). 14 analyst firms have reported ratings in the last year.
Current Stock Price for Exelixis (EXEL)?
The stock price for Exelixis (NASDAQ: EXEL) is $17.76 last updated February 8, 2023 at 9:00 PM UTC.
Does Exelixis (EXEL) pay a dividend?
There are no upcoming dividends for Exelixis.
When is Exelixis (NASDAQ:EXEL) reporting earnings?
Exelixis’s Q1 earnings are confirmed for Tuesday, May 9, 2023.
Is Exelixis (EXEL) going to split?
There is no upcoming split for Exelixis.
What sector and industry does Exelixis (EXEL) operate in?
Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Exelixis Stock (NASDAQ:EXEL), Quotes and News Summary
Exelixis Stock (NASDAQ: EXEL) stock price, news, charts, stock research, profile.
| Day Range16.990 - 17.930 | 52 Wk Range14.870 - 23.400 | Open / Close17.000 / 17.760 | Float / Outstanding285.391M / 324.087M |
| Vol / Avg.3.425M / 2.323M | Mkt Cap5.756B | P/E31.714 | 50d Avg. Price16.650 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float285.391M | EPS0.960 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-09 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.030 | 0.0900 | ||||
| REV | 417.500M | 423.917M | 6.417M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Exelixis (EXEL) stock?
You can purchase shares of Exelixis (NASDAQ: EXEL) through any online brokerage.
Who are Exelixis's (EXEL) competitors?
Other companies in Exelixis’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Exelixis (EXEL) stock?
The latest price target for Exelixis (NASDAQ: EXEL) was reported by Piper Sandler on Wednesday, February 8, 2023. The analyst firm set a price target for 32.00 expecting EXEL to rise to within 12 months (a possible 80.18% upside). 14 analyst firms have reported ratings in the last year.
Current Stock Price for Exelixis (EXEL)?
The stock price for Exelixis (NASDAQ: EXEL) is $17.76 last updated February 8, 2023 at 9:00 PM UTC.
Does Exelixis (EXEL) pay a dividend?
There are no upcoming dividends for Exelixis.
When is Exelixis (NASDAQ:EXEL) reporting earnings?
Exelixis’s Q1 earnings are confirmed for Tuesday, May 9, 2023.
Is Exelixis (EXEL) going to split?
There is no upcoming split for Exelixis.
What sector and industry does Exelixis (EXEL) operate in?
Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Exelixis Stock (NASDAQ:EXEL), Quotes and News Summary
Exelixis Stock (NASDAQ: EXEL) stock price, news, charts, stock research, profile.
| Day Range16.990 - 17.930 | 52 Wk Range14.870 - 23.400 | Open / Close17.000 / 17.760 | Float / Outstanding285.391M / 324.087M |
| Vol / Avg.3.425M / 2.323M | Mkt Cap5.756B | P/E31.714 | 50d Avg. Price16.650 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float285.391M | EPS0.960 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-09 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.120 | -0.030 | 0.0900 | ||||
| REV | 417.500M | 423.917M | 6.417M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Exelixis (EXEL) stock?
You can purchase shares of Exelixis (NASDAQ: EXEL) through any online brokerage.
Who are Exelixis's (EXEL) competitors?
Other companies in Exelixis’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Exelixis (EXEL) stock?
The latest price target for Exelixis (NASDAQ: EXEL) was reported by Piper Sandler on Wednesday, February 8, 2023. The analyst firm set a price target for 32.00 expecting EXEL to rise to within 12 months (a possible 80.18% upside). 14 analyst firms have reported ratings in the last year.
Current Stock Price for Exelixis (EXEL)?
The stock price for Exelixis (NASDAQ: EXEL) is $17.76 last updated February 8, 2023 at 9:00 PM UTC.
Does Exelixis (EXEL) pay a dividend?
There are no upcoming dividends for Exelixis.
When is Exelixis (NASDAQ:EXEL) reporting earnings?
Exelixis’s Q1 earnings are confirmed for Tuesday, May 9, 2023.
Is Exelixis (EXEL) going to split?
There is no upcoming split for Exelixis.
What sector and industry does Exelixis (EXEL) operate in?
Exelixis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.